PMID- 23339456 OWN - NLM STAT- MEDLINE DCOM- 20130711 LR - 20211021 IS - 1465-993X (Electronic) IS - 1465-9921 (Print) IS - 1465-9921 (Linking) VI - 14 IP - 1 DP - 2013 Jan 22 TI - Loss of alveolar membrane diffusing capacity and pulmonary capillary blood volume in pulmonary arterial hypertension. PG - 6 LID - 10.1186/1465-9921-14-6 [doi] AB - BACKGROUND: Reduced gas transfer in patients with pulmonary arterial hypertension (PAH) is traditionally attributed to remodeling and progressive loss of pulmonary arterial vasculature that results in decreased capillary blood volume available for gas exchange. METHODS: We tested this hypothesis by determination of lung diffusing capacity (DL) and its components, the alveolar capillary membrane diffusing capacity (D(m)) and lung capillary blood volume (V(c)) in 28 individuals with PAH in comparison to 41 healthy individuals, and in 19 PAH patients over time. Using single breath simultaneous measure of diffusion of carbon monoxide (DL(CO)) and nitric oxide (DL(NO)), DL and D(m) were respectively determined, and V(c) calculated. D(m) and V(c) were evaluated over time in relation to standard clinical indicators of disease severity, including brain natriuretic peptide (BNP), 6-minute walk distance (6MWD) and right ventricular systolic pressure (RVSP) by echocardiography. RESULTS: Both DL(CO) and DL(NO) were reduced in PAH as compared to controls and the lower DL in PAH was due to loss of both D(m) and V(c) (all p < 0.01). While DL(CO) of PAH patients did not change over time, DL(NO) decreased by 24 ml/min/mmHg/year (p = 0.01). Consequently, D(m) decreased and V(c) tended to increase over time, which led to deterioration of the D(m)/V(c) ratio, a measure of alveolar-capillary membrane functional efficiency without changes in clinical markers. CONCLUSIONS: The findings indicate that lower than normal gas transfer in PAH is due to loss of both D(m) and V(c), but that deterioration of D(m)/V(c) over time is related to worsening membrane diffusion. FAU - Farha, Samar AU - Farha S AD - Respiratory Institute, Cleveland Clinic, Cleveland, OH 44195, USA. farhas@ccf.org FAU - Laskowski, Daniel AU - Laskowski D FAU - George, Deepa AU - George D FAU - Park, Margaret M AU - Park MM FAU - Tang, W H Wilson AU - Tang WH FAU - Dweik, Raed A AU - Dweik RA FAU - Erzurum, Serpil C AU - Erzurum SC LA - eng GR - R37 HL060917/HL/NHLBI NIH HHS/United States GR - U10 HL109250/HL/NHLBI NIH HHS/United States GR - UL1 TR000439/TR/NCATS NIH HHS/United States GR - HL60917/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20130122 PL - England TA - Respir Res JT - Respiratory research JID - 101090633 SB - IM MH - Adult MH - *Blood Volume MH - Capillaries/*physiopathology MH - Diffusion MH - Familial Primary Pulmonary Hypertension MH - Female MH - Humans MH - Hypertension, Pulmonary/*physiopathology MH - Male MH - Pulmonary Alveoli/chemistry/*physiopathology MH - *Pulmonary Diffusing Capacity PMC - PMC3560152 EDAT- 2013/01/24 06:00 MHDA- 2013/07/13 06:00 PMCR- 2013/01/22 CRDT- 2013/01/24 06:00 PHST- 2012/10/23 00:00 [received] PHST- 2013/01/17 00:00 [accepted] PHST- 2013/01/24 06:00 [entrez] PHST- 2013/01/24 06:00 [pubmed] PHST- 2013/07/13 06:00 [medline] PHST- 2013/01/22 00:00 [pmc-release] AID - 1465-9921-14-6 [pii] AID - 10.1186/1465-9921-14-6 [doi] PST - epublish SO - Respir Res. 2013 Jan 22;14(1):6. doi: 10.1186/1465-9921-14-6.